A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations

Clinical Therapeutics

Volumn 30, Issue 5, 2008, Pages 800-812

  Robles, Gisela I ^a   Singh Franco, Devada ^a   Ghin, Hoytin Lee ^b  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

African American; Alaska Native; American Indian; black; bupropion SR; cotinine; ethnic; groups; Hispanic; Islander; minority groups; nicotine; nicotine replacement; nonwhite; Pacific; race; smoking cessation; therapy

Indexed keywords

AMFEBUTAMONE; CARBON MONOXIDE; COTININE; NICOTINE; NICOTINE GUM; PLACEBO; VARENICLINE;

ABSTINENCE; AFRICAN AMERICAN; AMERICAN INDIAN; ARTICLE; BEHAVIOR MODIFICATION; CIGARETTE SMOKING; COPING BEHAVIOR; CULTURAL FACTOR; ETHNICITY; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; MINORITY GROUP; NICOTINE REPLACEMENT THERAPY; PATIENT COUNSELING; PATIENT EDUCATION; PREDICTION; REFERENCE DATABASE; RELAXATION TRAINING; SALIVA LEVEL; SELF REPORT; SMOKING CESSATION; SUSTAINED DRUG RELEASE; THERAPY EFFECT; TOBACCO DEPENDENCE; TREATMENT RESPONSE; UNITED STATES; UNSPECIFIED SIDE EFFECT;

AFRICAN AMERICANS; BUPROPION; HISPANIC AMERICANS; HUMANS; NICOTINE; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 44949172432     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2008.05.010     Document Type: Article

References (52)

1. Centers for Disease Control and Prevention. Annual smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 1997-2001. MMWR 54 (2005) 625-628
2. Rock V., Malarcher A., Kahende J., et al. Cigarette smoking among adults-United States, 2006. MMWR 56 (2007) 1157-1161
3. O'Brien C. Drug addiction and drug abuse. In: Molinoff P., and Ruddon R. (Eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics. 9th ed (1996), McGraw-Hill, New York, NY 557-577
4. Public Health Service. Tobacco Use Among US Racial/Ethnic Minority Groups: African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders, and Hispanics: A Report of the Surgeon General. Washington, DC: US Government Printing Office; 1998. S/N 017-001-00527-4.
5. Silagy C., Lancaster T., Stead L., et al. Nicotine replacement therapy for smoking cessation [CD-ROM]. Cochrane Database Syst Rev 3 (2004) CD000146
6. Hughes J., Stead L., and Lancaster T. Antidepressants for smoking cessation [CD-ROM]. Cochrane Database Syst Rev 1 (2007) CD000031
7. Gonzales D., Rennard S., Nides M., et al., Varenicline Phase 3 Study Group. Varenicline, an α4B2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial. JAMA 296 (2006) 47-55
8. Jorenby D., Hays J., Rigotti N., et al., Varenicline Phase 3 Study Group. Efficacy of varenicline, an α4B2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial. [published correction appears in JAMA. 2006;296:1355]. JAMA 296 (2006) 56-63
9. Kabat G., and Morabia A. Comparison of smoking habits of blacks and whites in a case-control study. Am J Public Health 81 (1991) 1483-1486
10. Davidson M., Epstein M., Burt R., et al. Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. Arch Fam Med 7 (1998) 569-574
11. Kalman D., Kahler C., Garvey A., and Monti P. High-dose nicotine patch therapy for smokers with a history of alcohol dependence: 36-Week outcomes. J Subst Abuse Treat 30 (2006) 213-217
12. Shiffman S., Dresler C., Hajek P., et al. Efficacy of a nicotine lozenge for smoking cessation. Arch Intern Med 162 (2002) 1267-1276
13. Hays J., Hurt R., Rigotti N., et al. Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation: A randomized, controlled trial. Ann Intern Med 135 (2001) 423-433
14. Hurt R., Sachs D., Glover E., et al. A comparison of sustainedrelease bupropion and placebo for smoking cessation. N Engl J Med 337 (1997) 1195-1202
15. US Census Bureau News. Nation's population one-third minority. http://www.census.gov/PressRelease/www/releases/archives/facts_for_featu res_special_editions/007489.html. Accessed December 14, 2007.
16. Pinsky P. Racial and ethnic differences in lung cancer incidence: How much is explained by differences in smoking patterns? (United States). Cancer Causes Control 17 (2006) 1017-1024
17. Centers for Disease Control and Prevention. African Americans and tobacco. Atlanta, Ga: CDC; 2005.
18. Population by Sex, Age, Hispanic Origin and Race: 2004 [US Census Bureau Web site]. http://www.census.gov/population/socdemo/hispanic/ASEC2004/2004CPS_tab1. 1a.html. Accessed December 14, 2007.
19. Centers for Disease Control and Prevention. Tobacco use among adults.United States, 2005. MMWR 55 (2006) 1145-1148
20. Centers for Disease Control and Prevention. Health, United States, 2002 with Chartbook on Trends in the Health of Americans (2002), National Center for Health Statistics, Hyattsville, Md
21. Denny C., Holzman D., Goins R., and Croft J. Disparities in chronic disease risk factors and health status between American Indian/Alaska Native and White elders: Findings from a telephone survey, 2001 and 2002. Am J Public Health 95 (2005) 825-827
22. Doshi S., and Jiles R. Health behaviors among American Indian/Alaska Native women, 1998-2000 BRFSS. J Womens Health 15 (2006) 919-927
23. Centers for Disease Control and Prevention, Health, United States, 2005 with Chartbook on Trends in the Health of Americans (2005), National Center for Health Statistics, Hyattsville, Md
24. Pérez-Stable E., Marín G., and Posner S. Ethnic comparison of attitudes and beliefs about cigarette smoking. J Gen Intern Med 13 (1998) 167-174
25. Houston T., Scarinci I., Person S., and Greene P. Patient smoking cessation advice by health care providers: The role of ethnicity, socioeconomic status, and health. Am J Public Health 95 (2005) 1056-1061
26. Ranney L., Melvin C., Lux L., et al. Systematic review: Smoking cessationinterventionstrategiesforadults and adults in special populations. Ann Intern Med 145 (2006) 845-856
27. Royce J., Hymowitz N., Corbett K., et al., COMMIT Research Group. Smoking cessation factors among African Americans and whites. Am J Public Health 83 (1993) 220-226
28. Pérez-Stable E., Herrera B., Jacob III P., and Benowitz N. Nicotine metabolism and intake in black and white smokers. JAMA 280 (1998) 152-156
29. Ahluwalia J., McNagny S., and Clark W. Smoking cessation among inner-city African Americans using the nicotine transdermal patch. J Gen Intern Med 13 (1998) 1-8
30. Ahluwalia J., Harris K., Catley D., et al. Sustained-release bupropion for smoking cessation in African Americans: A randomized controlled trial. JAMA 288 (2002) 468-474
31. Ahluwalia J., Okuyemi K., Nollen N., et al. The effects of nicotine gum and counseling among African American light smokers: A 2x2 factorial design. Addiction 101 (2006) 883-891
32. Okuyemi K., Ahluwalia J., Ebersole-Robinson M., et al. Does menthol attenuate the effect of bupropion among African American smokers?. Addiction 98 (2003) 1387-1393
33. Harris K., Okuyemi K., Catley D., et al. Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropion. Prev Med 38 (2004) 498-502
34. Okuyemi K., Faseru B., Sanderson Cox L., et al. Relationship between menthol cigarettes and smoking cessation among African American light smokers. Addiction 102 (2007) 1979-1986
35. Leischow S., Hill A., and Cook G. Nicotine for the treatment of Hispanic smokers. Am J Health Behav 20 (1996) 304-311
36. Hensel M., Cavanagh T., Lanier A., et al. Quit rates at one year followup of Alaska Native Medical Center Tobacco Cessation Program. Alaska Med 37 (1995) 43-47
37. NicoDerm CQ (nicotine transdermal patch) [package insert]. Research Triangle Park, NC: United Therapeutics; 2006.
38. Heatherton T., Kozlowski L., Frecker R., and Fagerström K. The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. Br J Addict 86 (1991) 1119-1127
39. Zyban (bupropion SR hydrochloride) [package insert]. Research Triangle Park, NC: United Therapeutics; 2006.
40. Nicorette (nicotine gum) [package insert]. Research Triangle Park, NC: United Therapeutics; 2006.
41. Winkleby M., Schooler C., Kraemer H., et al. Hispanic versus white smoking patterns by sex and level of education. Am J Epidemiol 142 (1995) 410-418
42. Levinson A., Pérez-Stable E., Espinoza P., et al. Latinos report less use of pharmaceutical aids when trying to quit smoking. Am J Prev Med 26 (2004) 105-111
43. Levinson A., Borrayo E., Espinoza P., et al. An exploration of Latino smokers and the use of pharmaceutical aids. Am J Prev Med 31 (2006) 167-171
44. Fu S., Sherman S., Yano E., et al. Ethnic disparities in the use of nicotine-replacement therapy for smoking cessation in an equalaccess health care system. Am J Health Promotion 20 (2005) 108-116
45. Marin G., Sabogal F., Marin B., et al. Development of a Short Acculturation Scale for Hispanics: Special issue acculturation research. Hispanic J Behav Sci 9 (1987) 183-205
46. Choi W., Daley C., James A., et al. Beliefs and attitudes regarding smoking cessation among American Indians: A pilot study. Ethn Dis 16 (2006) 35-40
47. Lerman C., Kaufmann V., Rukstalis M., et al. Individualizing nicotine replacement theraphy for the treatment of tobacco dependence: A randomized controlled trial. Ann Intern Med 140 (2004) 426-433
48. Nicotrol (nicotine inhalation system) [package insert]. Morris Plains, NJ: Pfizer Inc; 2005.
49. Mueller K., Patil K., and Boilesen E. The role of uninsurance and race in healthcare utilixation by rural minorities. Health Serv Res 33 (1998) 597-610
50. Castro F. Physiological, physiological, social, and cultural influence on the use of menthol cigarettes among blacks and Hispanics. Nicotine & Tobacco Research 6 Suppl (2004) S29-S41
51. US Dept of Health and Human Services. The health benefits of smoking cessation: A report of the Surgeon General (1990), DHHS, Centers for Disease Control and Prevention, Rockville, Md
52. Gritz E., Fingeret M., Vidrine D., et al. Success and failures of the teachable moment: Smoking cessation in cancer patients. Cancer 106 (2006) 17-27